Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
CA 2477662 A1 · Owner: Schneider, Christophe · Inventors: Al-Mahmood, Salman; Schneider, Christophe; Colin, Sylvie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to therapeutic compositions used in the field of angiogenesis comprising nucleotide sequences of genes the involvement of said genes in the angiogenesis mechanism having been demonstrated by the applicant and including the complementary sequences thereof the antisense sequences of same, polypeptide sequences coded by the coding parts of the aforementioned genes and antibodies that are directed against said polypeptide sequences. The invention also relates to genetically-modified cells that underexpress or overexpress the above-mentioned genes and to therapeutic compositions containing said cells which are used to treat angiogenic disorders. Moreover the invention …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 4, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 4, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 4, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.